Press Release: Syncona : Syncona invests 15mn in Oxford University spin out, OMass Therapeutics
ollowing the Series B financing, Syncona has revalued its existing investment which has resulted in a 32% uplift in the value of its stake in OMass Therapeutics.
Read full article »
Syncona is an England-based venture capital firm that invests in early-stage startups.
Read more